We are live on ! Find out more
BIOSU

BioPlus Acquisition Corp. Unit
BIOSU

Delisted

BIOSU was delisted on the 6th of October, 2023.

Back to rankings

11 hedge funds and large institutions have $9.41M invested in BioPlus Acquisition Corp. Unit in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% less funds holding

Funds holding: 15 → 11 (-4)

60% less capital invested

Capital invested by funds: $23.7M → $9.41M (-$14.3M)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
11
Holders Change
-4
Holders Change %
-26.67%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$104K

Top Sellers

Rank Fund Capital Flow
1
Calamos Advisors
Calamos Advisors
Illinois
-$10.1M
2
LP
LMR Partners
United Kingdom
-$2.51M
3
WC
Wealthspring Capital
New York
-$1.52M
4
PCM
Prelude Capital Management
New York
-$251K
5
SIA
Schechter Investment Advisors
Michigan
-$195K

BIOSU Hedge Fund Activity: Q4 2022 in Review

11 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Unit (BIOSU) for Q4 2022, worth a combined $9.41M — down 60% from $23.7M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of BIOSU and 2 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 0 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $104K. The largest seller was Calamos Advisors, exiting entirely with an estimated $10.1M sold.

  • 11 institutional investors held BioPlus Acquisition Corp. Unit (BIOSU) as of Q4 2022, down from 15 in Q3 2022.
  • Funds reported $9.41M of BioPlus Acquisition Corp. Unit stock for Q4 2022, down 60% quarter-over-quarter.
  • 2 funds opened new BioPlus Acquisition Corp. Unit positions in Q4 2022 and 6 closed out, a net change of -4 holders.
  • The largest BioPlus Acquisition Corp. Unit buyer in Q4 2022 was Susquehanna International Group, an estimated $104K added.
  • The largest BioPlus Acquisition Corp. Unit seller in Q4 2022 was Calamos Advisors, an estimated $10.1M sold.

Based on aggregated 13F filings for Q4 2022.